Note 10 - Earnings Per Share The following tables set forth the computation of basic and diluted net income per share of common stock: | | | | | | | | | | | | | Three Months Ended March 31, | (in millions, except shares and per share amounts) | 2026 | | 2025 | | Basic net income per share attributable to common stockholders | | | | | Numerator: | | | | | Net income | $ | 29.3 | | | $ | 26.8 | | | Denominator: | | | | | Weighted average number of shares of common stock outstanding | 302,451,474 | | | 340,741,847 | | | Basic net income per share attributable to common stockholders | $ | 0.10 | | | $ | 0.08 | | | | | | | Diluted net income per share attributable to common stockholders | | | | | Numerator: | | | | | Net income | $ | 29.3 | | | $ | 26.8 | | | Denominator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted average shares of common stock outstanding used to calculate diluted net income per share | 302,451,474 | | | 340,741,847 | | | Diluted net income per share attributable to common stockholders | $ | 0.10 | | | $ | 0.08 | |
Potentially dilutive securities excluded due to their anti-dilutive effect were as follows: | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | 2026 | | 2025 | | | | | | | | | | | | | | Restricted stock units | 14,134,205 | | | 13,614,370 | | | | | | | | | | | | | | | CEO Premium-Priced Performance Option | 9,678,000 | | | — | | | | | | | Exercise of common stock options | 189,014 | | | 226,924 | | | | | | | Total anti-dilutive securities | 24,001,219 | | | 13,841,294 | | | | | |
For a description of the terms and conditions of these securities, refer to Note 13 – Equity-Based Compensation in our 2025 Form 10-K.
|